文献速递外周动脉疾病

择期外周血管介入与间歇性跛行患者结局的关联

Association of elective peripheral vascular intervention with outcomes among patients with peripheral arterial disease and intermittent claudication.
PubMed 文献 · J Vasc Surg · 2026-06-12

基于OptumLabs数据仓库的商业保险与Medicare Advantage人群,纳入新诊断外周动脉疾病合并间歇性跛行的成人,按1:1倾向性匹配比较择期外周血管介入与未介入者。匹配后26716例中,择期PVI与更高的主要不良肢体事件风险及更高总费用相关,提示需重新评估该人群PVI的日益广泛应用。

要点

  • 择期PVI与主要不良肢体事件风险升高相关(IRR 2.20,95%CI 2.04-2.38)。
  • 择期PVI组12个月内26.0%接受再次手术,总费用均值更高。
  • 应重新评估间歇性跛行患者中PVI的日益使用。

核心结论

  • 在PAD合并IC的大型真实世界研究中,择期PVI与更高的MALE风险及更高费用相关,作者认为应据此重新评估该人群PVI的日益使用。

研究设计与样本

  • 采用回顾性队列分析,数据来自OptumLabs Data Warehouse,覆盖2016年1月1日至2023年9月30日的商业保险与Medicare Advantage人群。
  • 纳入18岁及以上、新诊断PAD合并IC的患者,按1:1倾向性匹配比较择期PVI与未行PVI者;匹配变量包括人口学、日历年份、合并症、PAD相关药物、门诊就诊与基线费用。
  • 主要结局为MALE(新发大截肢、新发急性肢体缺血、进展为慢性肢体威胁性缺血复合终点),限于连续入组12个月的患者;次要结局包括30天延迟后的后续PVI与医疗费用。

主要发现

  • 匹配后共26716例,平均年龄70.5岁,41%为女性。
  • 择期PVI与更高的MALE风险相关(IRR 2.20;95%CI 2.04-2.38),包括新发大截肢(IRR 4.01;95%CI 2.45-6.55)、新发急性肢体缺血(IRR 1.94;95%CI 1.73-2.18)和进展为慢性肢体威胁性缺血(IRR 2.43;95%CI 2.22-2.67)。
  • 接受择期PVI的13358例中,3477例(26.0%)在初次PVI后第2至12个月接受再次手术。
  • 择期PVI与更高的平均总医疗费用相关:44934美元对比26452美元(费用比1.70;95%CI 1.65-1.75)。

临床怎么用

  • 对PAD合并间歇性跛行患者选择择期PVI时,应结合MALE风险升高与费用增加的证据进行共同决策。
  • 术后第2至12个月需关注再次手术风险,本队列中26.0%接受了重复手术。

局限性

  • 为回顾性倾向性匹配队列分析,非随机对照,残余混杂无法排除。
  • 数据来源限于商业保险与Medicare Advantage人群,外推需谨慎。
  • MALE分析限于连续入组12个月的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral vascular intervention (PVI) is increasingly used for the treatment of peripheral arterial disease (PAD) with intermittent claudication (IC). However, large, real-world comparative studies of the safety and effectiveness of PVI compared with no PVI are limited. We sought to compare the effectiveness and costs of elective PVI compared with no PVI among patients with PAD and IC. METHODS: We conducted a 1:1 propensity-matched retrospective cohort analysis of commercially insured and Medicare Advantage patients in OptumLabs Data Warehouse from January 1, 2016, to September 30, 2023. Patients aged 18 years and older with incident diagnosis codes for PAD with IC were included. Patients undergoing elective PVI were matched to those who did not receive PVI based on demographics, calendar year, comorbidities, PAD-related medications, office visits, and baseline costs. The primary outcome was major adverse limb events (MALE), defined as a composite of new major amputation, new acute limb ischemia, and progression to chronic limb-threatening ischemia among patients with 12-months continuous enrollment. Secondary outcomes included subsequent PVI after a 30-day delay and costs of care. RESULTS: Among 26,716 propensity-matched patients, mean age was 70.5 years, and 41% of patients were women. Elective PVI was associated with a higher risk of MALE [incidence rate ratio (IRR), 2.20; 95% confidence interval (CI), 2.04-2.38], including new major amputations (IRR, 4.01; 95% CI, 2.45-6.55), new acute limb ischemia (IRR, 1.94; 95% CI, 1.73-2.18), and progression to chronic limb-threatening ischemia (IRR, 2.43; 95% CI, 2.22-2.67). Among the 13,358 patients who received elective PVI, 3477 patients (26.0%) received a repeat procedure during months 2 to 12 following the initial PVI. Elective PVI treatment was also associated with higher mean total cost of care, $44,934 compared with $26,452 among patients who did not receive PVI (cost ratio, 1.70; 95% CI, 1.65-1.75). CONCLUSIONS: In this large real-world study of patients with PAD and IC, elective PVI was associated with increased MALE compared with no PVI. These findings should inform a re-evaluation of the increasing use of PVI in this population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dhruva SS, Murillo J, Ameli O, et al. Association of elective peripheral vascular intervention with outcomes among patients with peripheral arterial disease and intermittent claudication. J Vasc Surg. 2026. PMID: 42285183. doi:10.1016/j.jvs.2026.05.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。